Cell-based Biological Reagents Market Forecast Signals New Revenue Opportunities Through 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Cell-based Biological Reagents Market Revenue Outlook: What CAGR Is Expected Through 2030?
The cell-based biological reagents market has experienced substantial growth in recent years. It is anticipated to expand from $13.78 billion in 2025 to $14.93 billion by 2026, at a compound annual growth rate (CAGR) of 8.3%. This historical expansion is attributable to several key factors, including the increasing scope of drug discovery research activities, higher spending on pharmaceutical R&D, the growing utilization of cell-based assays in toxicity testing, ongoing advancements in cell culture technologies, and the increasing uptake of standardized biological reagents.
The cell-based biological reagents market is projected to experience substantial growth in the upcoming years. It is expected to reach $20.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is attributed to the increasing demand for predictive in vitro models, the broadening scope of personalized medicine research, the growing utilization of AI-driven drug screening, rising investments in regenerative medicine studies, and an increased focus on complex disease modeling. Key trends in this period include the increasing adoption of 3D cell culture and assay platforms, a rise in the use of gene-edited and reporter cell lines, a growing demand for high-throughput cell-based screening, the expansion of stem cell and primary cell applications, and an enhanced emphasis on physiologically relevant models.
Download A Free Sample Report For Comprehensive Market Insights:
Cell-based Biological Reagents Market Growth Momentum: Which Factors Are Influencing Demand?
The increasing emphasis on cell and gene therapies is anticipated to drive expansion in the cell-based biological reagents market in the future. These therapies involve utilizing live cells or genetic content to mend, substitute, or alter impaired cells or genes, aiming to treat or cure illnesses. The adoption of cell and gene therapies is escalating due to the growing occurrence of rare and genetic conditions, as these treatments address the root causes at a cellular or genetic level, potentially offering cures rather than just symptom management provided by traditional methods. Cell-based biological reagents facilitate cell and gene therapies by providing the necessary instruments and substances for the efficient cultivation, modification, and delivery of therapeutic cells or genetic material. As an illustration, IQVIA Holdings Inc., a US-based healthcare firm specializing in clinical research services and analytics, reported in March 2024 that worldwide expenditure on cell and gene therapies soared to $5.9 billion in 2023, marking a 38% rise compared to 2022. Consequently, the heightened concentration on cell and gene therapies is stimulating the expansion of the cell-based biological reagents market.
Cell-based Biological Reagents Market Segment Analysis: What Are The Major Market Categories?
The cell-based biological reagents market covered in this report is segmented –
1) By Product Type: Assay Kits; Cell Lines; Reagents; Other Product Types
2) By Technology: Two Dimensional Cell Culture; Three Dimensional Cell Culture; High Throughput Screening Platforms; Stem Cell Technologies; Gene Edited Cell Platforms
3) By Application: Drug Discovery And Development; Toxicology And Safety Assessment; Disease Modeling; Regenerative Medicine; Basic Research
4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Clinical And Diagnostic Laboratories; Government And Public Health Agencies
Subsegments:
1) By Assay Kits: Cell Viability Assay Kits; Cytotoxicity Assay Kits; Proliferation Assay Kits; Apoptosis Assay Kits; Signal Transduction Assay Kits
2) By Cell Lines: Primary Cell Lines; Immortalized Cell Lines; Stem Cell Lines; Cancer Cell Lines; Transfected Cell Lines
3) By Reagents: Culture Media Reagents; Growth Factor Reagents; Enzyme Reagents; Supplement Reagents; Antibody Reagents
4) By Other Product Types: Cryopreservation Reagents; Labware Consumables; Transfection Reagents; Cell Sorting Reagents; Custom Reagents
Cell-based Biological Reagents Market Trends Reshaping Industry Growth
Major companies operating in the cell-based biological reagents market are concentrating on developing human-induced pluripotent stem cell (iPSC) research products to progress drug discovery, disease modeling, and regenerative medicine applications. Human-induced pluripotent stem cell (iPSC) research products refer to integrated tools and workflows that enable the generation, maintenance, differentiation, and analysis of iPSCs for applications in biomedical research, including drug testing, disease modeling, and cell therapy development. For instance, in July 2024, BioServe Biotechnologies (India) Private Limited, an India-based biotechnology company, launched an advanced stem cell product line to further regenerative medicine and drug development research. This line enhances biotech research through reliable iPSC generation, 3D organoid cultures, and targeted differentiation tools, minimizing experimental variability. They streamline drug discovery by offering human-specific models that reduce animal testing and accelerate toxicity assessments for quicker therapy development. Ultimately, they empower personalized medicine, enabling tissue regeneration for diseases such as diabetes or heart failure while simultaneously reducing costs and rejection risks.
Cell-based Biological Reagents Market Leading Companies Driving Competitive Growth
Major companies operating in the cell-based biological reagents market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Corp., Danaher Corporation, GE Healthcare, Becton, Dickinson And Company, Corning Incorporated, Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec, Abcam plc, Promega Corporation, Takara Bio Inc., R&D Systems Inc., MP Biomedicals, Sino Biological, Cell Signaling Technology Inc., InvivoGen, Tocris Bioscience, and OPM Biosciences.
Access The Complete Cell-based Biological Reagents Market Report:
Cell-based Biological Reagents Market Geographic Distribution And Regional Opportunities
North America was the largest region in the cell-based biological reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-based biological reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
